AnalystsAndrew FeinAndrew Fein's Stock Forecasts
AnalystsAndrew Fein
Analyst Ranking
Bottom 9%
#3769 out of 4126 analysts
Average Return
-2.23%
Win Rate
39%50 out of 128
Risk vs Reward
Poor
Good
Andrew Fein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Wave Life Sciences LtdWVE | +241.46% | $1.23 | $4.20 | 2022-05-12 - 2022-12-02 | Buy |
Bellerophon Therapeutics IncBLPH | +234.33% | $10.05 | $33.60 | 2017-01-19 - 2018-01-19 | Buy |
Epizyme IncEPZM | +183.24% | $0.52 | $1.47 | 2022-06-02 - 2022-08-11 | Buy |
Kalvista Pharmaceuticals IncKALV | +174.23% | $10.40 | $28.52 | 2020-06-14 - 2021-06-15 | Buy |
Epizyme IncEPZM | +173.74% | $0.54 | $1.47 | 2022-05-11 - 2022-08-11 | Buy |
Andrew Fein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Syros Pharmaceuticals IncSYRS | 5 | Buy | $20.00 | +400.00% | Maintains | 18 days ago |
Unity Biotechnology IncUBX | 2 | Buy | $10.00 | +258.42% | Maintains | 24 days ago |
Sutro Biopharma IncSTRO | 2 | Buy | $20.00 | +181.69% | Maintains | 24 days ago |
Merus NvMRUS | 4 | Buy | $39.00 | +160.52% | Maintains | a month ago |
United Therapeutics CorpUTHR | 4 | Buy | $300.00 | +7.70% | Maintains | a month ago |
Blueprint Medicines CorpBPMC | 4 | Buy | $70.00 | +43.06% | Maintains | a month ago |
Seagen IncSGEN | 4 | Buy | $180.00 | +47.05% | Maintains | a month ago |
Biogen IncBIIB | 5 | Buy | $325.00 | +8.73% | Maintains | a month ago |
Amylyx Pharmaceuticals IncAMLX | 2 | Buy | $50.00 | +27.45% | Maintains | a month ago |
Kalvista Pharmaceuticals IncKALV | 3 | Buy | $16.00 | +197.40% | Maintains | 2 months ago |
Deciphera Pharmaceuticals IncDCPH | 7 | Buy | $25.00 | +59.74% | Maintains | 3 months ago |
I MabIMAB | 5 | Buy | $45.00 | +1,078.01% | Maintains | 3 months ago |
Vigil Neuroscience IncVIGL | 1 | Buy | $24.00 | +88.24% | Initiates Coverage On | 3 months ago |
Proqr Therapeutics NvPRQR | 3 | Buy | $1.50 | +11.11% | Maintains | 4 months ago |
Bellus Health IncBLU | 4 | Buy | $20.00 | +96.08% | Maintains | 4 months ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Buy | $18.00 | +4.23% | Maintains | 4 months ago |
Foghorn Therapeutics IncFHTX | 3 | Buy | $25.00 | +248.68% | Maintains | 4 months ago |
Zentalis Pharmaceuticals IncZNTL | 5 | Buy | $55.00 | +151.26% | Maintains | 4 months ago |
Protara Therapeutics IncTARA | 3 | Buy | $23.00 | +528.42% | Maintains | 4 months ago |
Acadia Pharmaceuticals IncACAD | 5 | Buy | $25.00 | +58.63% | Maintains | 4 months ago |
Arvinas IncARVN | 2 | Buy | $90.00 | +117.44% | Maintains | 4 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Buy | $300.00 | -6.65% | Maintains | 4 months ago |
Acumen Pharmaceuticals IncABOS | 1 | Buy | $15.00 | +167.86% | Initiates Coverage On | 5 months ago |
Theseus Pharmaceuticals IncTHRX | 1 | Buy | $22.00 | +237.42% | Initiates Coverage On | 5 months ago |
Fulcrum Therapeutics IncFULC | 3 | Buy | $20.00 | +196.30% | Maintains | 6 months ago |
Epizyme IncEPZM | 4 | Buy | $6.00 | +308.16% | Maintains | 6 months ago |
Wave Life Sciences LtdWVE | 1 | Buy | $8.00 | +90.48% | Maintains | 7 months ago |
Rubius Therapeutics IncRUBY | 3 | Buy | $8.00 | +3,709.52% | Maintains | 7 months ago |
Tscan Therapeutics IncTCRX | 2 | Buy | $15.00 | +564.30% | Maintains | 7 months ago |
Annexon IncANNX | 2 | Buy | $30.00 | +459.70% | Maintains | 7 months ago |
Eloxx Pharmaceuticals IncELOX | 4 | Hold | $0.50 | -87.89% | Maintains | 7 months ago |
C4 Therapeutics IncCCCC | 2 | Buy | $35.00 | +308.88% | Maintains | 7 months ago |
Amarin Corp PLCAMRN | 1 | Hold | $3.00 | +145.90% | Downgrades | 7 months ago |
Global Blood Therapeutics IncGBT | 2 | Buy | $65.00 | -5.10% | Maintains | 7 months ago |
Aldeyra Therapeutics IncALDX | 1 | Buy | $15.00 | +130.06% | Assumes | 7 months ago |
Pulmatrix IncPULM | 2 | Buy | $10.00 | +159.74% | Maintains | 8 months ago |
Mei Pharma IncMEIP | 1 | Buy | $5.00 | +1,104.82% | Maintains | 8 months ago |
Aprea Therapeutics IncAPRE | 3 | Hold | $2.00 | +316.67% | Maintains | 9 months ago |
Gemini Therapeutics IncGMTX | 2 | Hold | $2.00 | +16.28% | Downgrades | 9 months ago |
Quince Therapeutics IncQNCX | 4 | Buy | $15.00 | +1,954.79% | Maintains | 9 months ago |
Liquidia CorpLQDA | 1 | Buy | $16.00 | +191.44% | Maintains | 10 months ago |
Dbv Technologies SaDBVT | 1 | Buy | $10.00 | +651.88% | Maintains | a year ago |
Ocuphire Pharma IncOCUP | 1 | Buy | $26.00 | N/A | Initiates Coverage On | a year ago |
Biocryst Pharmaceuticals IncBCRX | 2 | Buy | $30.00 | N/A | Maintains | a year ago |
Denali Therapeutics IncDNLI | 2 | Buy | $105.00 | N/A | Maintains | a year ago |
Prothena Corp Public Ltd CoPRTA | 3 | Buy | $75.00 | N/A | Maintains | a year ago |
Yumanity Therapeutics IncYMTX | 1 | Buy | $39.00 | N/A | Initiates Coverage On | a year ago |
Ac Immune SaACIU | 2 | Buy | $16.00 | N/A | Maintains | 2 years ago |
Translate Bio IncTBIO | 2 | Buy | $28.00 | N/A | Maintains | 2 years ago |
Alector IncALEC | 1 | Buy | $41.00 | N/A | Initiates Coverage On | 2 years ago |
Neurocrine Biosciences IncNBIX | 1 | Buy | $131.00 | N/A | Maintains | 2 years ago |
Aimmune Therapeutics IncAIMT | 2 | Hold | $15.00 | N/A | Reiterates | 3 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Buy | $75.00 | N/A | Reiterates | 3 years ago |
Keros Therapeutics IncKROS | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Concert Pharmaceuticals IncCNCE | 3 | Buy | $26.00 | N/A | Maintains | 5 years ago |
Steadymed LtdSTDY | 1 | Buy | $15.00 | N/A | Reiterates | 6 years ago |
Bellerophon Therapeutics IncBLPH | 1 | Buy | $5.00 | N/A | Initiates Coverage On | 6 years ago |
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactStock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.